These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16106916)

  • 1. Prescription drug use and abuse. Risk factors, red flags, and prevention strategies.
    Isaacson JH; Hopper JA; Alford DP; Parran T
    Postgrad Med; 2005 Jul; 118(1):19-26. PubMed ID: 16106916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription drug abuse: executive summary of a policy position paper from the American College of Physicians.
    Kirschner N; Ginsburg J; Sulmasy LS;
    Ann Intern Med; 2014 Feb; 160(3):198. PubMed ID: 24323199
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can prescription drug monitoring programs help limit opioid abuse?
    Gugelmann HM; Perrone J
    JAMA; 2011 Nov; 306(20):2258-9. PubMed ID: 22110107
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medication dependency and physician's role].
    Holzbach R; Martens M; Kalke J; Raschke P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Apr; 53(4):319-25. PubMed ID: 20198358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?
    Peckham AM; Fairman KA; Sclar DA
    Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients.
    Yenikomshian MA; White AG; Carson ME; Garrison LP; Oderda GM; Biskupiak JE; Hlavacek PR; Roland CL
    J Opioid Manag; 2017; 13(5):291-301. PubMed ID: 29199395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Surgeon's Roles in Stemming the Prescription Opioid Abuse Epidemic.
    Hupp JR
    J Oral Maxillofac Surg; 2016 Jul; 74(7):1291-3. PubMed ID: 27156949
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescription drug abuse: when the treatment becomes the problem.
    Kemp A; Clark M; Sherman J; Dahl-Smith J
    J Miss State Med Assoc; 2013 May; 54(5):134, 139-40. PubMed ID: 23909210
    [No Abstract]   [Full Text] [Related]  

  • 10. Substance abuse in children: prediction, protection, and prevention.
    Belcher HM; Shinitzky HE
    Arch Pediatr Adolesc Med; 1998 Oct; 152(10):952-60. PubMed ID: 9790604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription drug abuse: problem, policies, and implications.
    Phillips J
    Nurs Outlook; 2013; 61(2):78-84. PubMed ID: 23245611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing claims for prescription drugs with a high potential for abuse.
    Hoffman L; Enders JL; Pippins J; Segal R
    Am J Health Syst Pharm; 2003 Feb; 60(4):371-4. PubMed ID: 12625220
    [No Abstract]   [Full Text] [Related]  

  • 13. Provider-patient communication about prescription drug abuse: A qualitative analysis of the perspective of prescribers.
    Mathis SM; Hagaman A; Hagemeier N; Baker K; Pack RP
    Subst Abus; 2020; 41(1):121-131. PubMed ID: 31403901
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic-use screening evaluations (ABUSE) for physicians and patients: featuring prizes and penalties for physicians.
    Lettau LA
    Infect Control Hosp Epidemiol; 2000 Dec; 21(12):796-9. PubMed ID: 11140918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug abuse--yes, it is our problem.
    Elmassian K
    Mich Med; 2013; 112(4):32. PubMed ID: 24044349
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixed message on prescription drug abuse.
    Vastag B
    JAMA; 2001 May; 285(17):2183-4. PubMed ID: 11325305
    [No Abstract]   [Full Text] [Related]  

  • 17. Discussing Opioid Risks With Patients to Reduce Misuse and Abuse: Evidence From 2 Surveys.
    Hero JO; McMurtry C; Benson J; Blendon R
    Ann Fam Med; 2016 Nov; 14(6):575-577. PubMed ID: 28376444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-medical use and abuse of commonly prescribed medications.
    Riggs P
    Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription medication abuse and illegitimate internet-based pharmacies.
    Jena AB; Goldman DP; Foster SE; Califano JA
    Ann Intern Med; 2011 Dec; 155(12):848-50. PubMed ID: 22184692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Academy of Pediatrics Committee on Substance Abuse: Role of the pediatrician in prevention and management of substance abuse.
    Pediatrics; 1993 May; 91(5):1010-3. PubMed ID: 8474792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.